SCHEMBL1396409

SCHEMBL1396409

CC(=O)C1CC=C(CCC=C(C)C)CC1

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
MAPT P10636 1/20 0.65
FNTA P49354 2/20 0.49
PKM P14618 1/20 0.49
PGGT1B P53609 1/20 0.49
MCL1 Q07820 10/20 0.46
BCL2L1 Q07817 5/20 0.46
FNTB P49356 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP1B1 Q16678 1/20 0.43
BCL2 P10415 7/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10811718 0.92 KMT2A (0.58) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL10811713 0.92 KMT2A (0.58) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL25329254 0.90 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL9414354 0.90 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL8837696 0.88 ALDH1A1 (0.70) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL15298583 0.86 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL27620370 0.85 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL21609550 0.84 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL9414348 0.84 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTFNTA
SCHEMBL15932814 0.83 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AMAPTFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197510-A1 DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS The Procter & Gamble Company (US) 2017-08-02 EP claimed
WO-2016049458-A1 DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
EP-2556139-A1 ENCAPSULATES The Procter & Gamble Company (US) 2013-02-13 EP claimed
EP-2555742-A1 ENCAPSULATES The Procter & Gamble Company (US) 2013-02-13 EP claimed
WO-2011127011-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2011-10-13 WO claimed
WO-2011127030-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2011-10-13 WO claimed
EP-1021160-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL NEDERLAND BV (NL) 2000-07-26 EP claimed
WO-1999018926-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 1999-04-22 WO claimed
EP-4225484-A1 HYBRID MICROCAPSULES COMPRISING A REGENERATED BIOPOLYMER Firmenich SA (CH) 2023-08-16 EP disclosed
EP-4225485-A1 HYBRID MICROCAPSULES COMPRISING LIGNIN PARTICLES Firmenich SA (CH) 2023-08-16 EP disclosed
EP-4196257-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES Firmenich SA (CH) 2023-06-21 EP disclosed
EP-4196256-A1 PROCESS FOR PREPARING MICROCAPSULES Firmenich SA (CH) 2023-06-21 EP disclosed
EP-4178715-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES Firmenich SA (CH) 2023-05-17 EP disclosed
WO-2022136008-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 WO disclosed
WO-2003033635-A1 CONTROLLED BENEFIT AGENT DELIVERY SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2003-04-24 WO disclosed
US-6413448-B1 ESTERS; DOPANTS; LONGER CHIRAL SMECTIC PHASE PITCH; HIGHER TILT ANGLE; LOWER VISCOSITY; CRYSTALLIZATION SUPPRESSION; IMPROVED SOLUBILITY; BROADER C* PHASE TEMPERATURE RANGE DISPLAYTECH, INC. 2002-07-02 US disclosed
WO-2000065801-A9 CYCLOHEXYL- AND CYCLOHEXENYL-SUBSTITUTED LIQUID CRYSTALS WITH LOW BIREFRINGENCE DISPLAYTECH INC (US) 2001-04-12 WO disclosed
WO-2000065801-A1 CYCLOHEXYL- AND CYCLOHEXENYL-SUBSTITUTED LIQUID CRYSTALS WITH LOW BIREFRINGENCE DISPLAYTECH, INC. (US) 2000-11-02 WO disclosed
EP-1021160-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL NEDERLAND BV (NL) 2000-07-26 EP disclosed
WO-1999018926-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 1999-04-22 WO disclosed